Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T21:30:42.117Z.
Calculation as of: 2026-10-06T21:30:42.117Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dce8aa4241063aa413a511fcc73ca02083e5b5875564fe7763a0d28183f25b54
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
245.87x
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Akebia Therapeutics, Inc.
Market Cap
$235.66M
EV/EBIT Ratio
N/A
TTM Avg
245.87x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.97M
EV/EBIT Ratio
N/A
TTM Avg
5.15x
3Y Avg
5.03x
5Y Avg
6.70x
Market Cap
$235.08M
EV/EBIT Ratio
22.90x
TTM Avg
12.07x
3Y Avg
10.11x
5Y Avg
11.81x
Market Cap
$239.01M
EV/EBIT Ratio
99.89x
TTM Avg
177.33x
3Y Avg
172.45x
5Y Avg
172.45x
Market Cap
$231.77M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $235.66M | N/A | 245.87x | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 5.15x | 5.03x | 6.70x |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 22.90x | 12.07x | 10.11x | 11.81x |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $232.72M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | 99.89x | 177.33x | 172.45x | 172.45x |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | N/A | 378.61x | 334476.42x | 334476.42x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-08-05 | 36.74x |
| 2026-08-04 | 38.26x |
| 2026-08-03 | 37.75x |
| 2026-07-31 | 38.26x |
| 2026-07-30 | 39.77x |
| 2026-07-29 | 35.23x |
| 2026-07-28 | 35.73x |
| 2026-07-27 | 36.24x |
| 2026-07-24 | 33.21x |
| 2026-07-23 | 33.21x |
| 2026-07-22 | 35.23x |
| 2026-07-21 | 37.25x |
| 2026-07-20 | 36.24x |
| 2026-07-17 | 39.27x |
| 2026-07-16 | 42.30x |
| 2026-07-15 | 41.29x |
| 2026-07-14 | 42.30x |
| 2026-07-13 | 41.29x |
| 2026-07-10 | 42.30x |
| 2026-07-09 | 43.81x |
| 2026-07-08 | 43.31x |
| 2026-07-07 | 40.28x |
| 2026-07-06 | 37.25x |
| 2026-07-02 | 34.22x |
| 2026-07-01 | 32.71x |
| 2026-06-30 | 29.17x |
| 2026-06-29 | 27.66x |
| 2026-06-26 | 29.17x |
| 2026-06-25 | 24.12x |
| 2026-06-24 | 25.13x |
| 2026-06-23 | 27.15x |
| 2026-06-22 | 26.65x |
| 2026-06-18 | 25.64x |
| 2026-06-17 | 23.11x |
| 2026-06-16 | 21.29x |
| 2026-06-15 | 19.01x |
| 2026-06-12 | 18.29x |
| 2026-06-11 | 17.02x |
| 2026-06-10 | 15.68x |
| 2026-06-09 | 18.06x |
| 2026-06-08 | 18.85x |
| 2026-06-05 | 18.84x |
| 2026-06-04 | 20.60x |
| 2026-06-03 | 20.57x |
| 2026-06-02 | 18.89x |
| 2026-06-01 | 23.11x |
| 2026-05-29 | 23.11x |
| 2026-05-28 | 24.63x |
| 2026-05-27 | 23.62x |
| 2026-05-26 | 24.12x |
| 2026-05-22 | 23.11x |
| 2026-05-21 | 23.11x |
| 2026-05-20 | 22.61x |
| 2026-05-19 | 16.81x |
| 2026-05-18 | 22.61x |
| 2026-05-15 | 25.13x |
| 2026-05-14 | 28.67x |
| 2026-05-13 | 31.19x |
| 2026-05-12 | 31.19x |
| 2026-05-11 | 29.68x |
| 2026-05-08 | 30.18x |
| 2026-05-07 | 7.66x |
| 2026-05-06 | 11.05x |
| 2026-05-05 | 10.71x |
| 2026-05-04 | 11.28x |
| 2026-05-01 | 10.15x |
| 2026-04-30 | 9.92x |
| 2026-04-29 | 9.70x |
| 2026-04-28 | 10.37x |
| 2026-04-27 | 10.37x |
| 2026-04-24 | 10.49x |
| 2026-04-23 | 10.49x |
| 2026-04-22 | 10.37x |
| 2026-04-21 | 10.26x |
| 2026-04-20 | 10.49x |
| 2026-04-17 | 10.26x |
| 2026-04-16 | 9.58x |
| 2026-04-15 | 11.84x |
| 2026-04-14 | 11.95x |
| 2026-04-13 | 10.94x |
| 2026-04-10 | 10.15x |
| 2026-04-09 | 10.26x |
| 2026-04-08 | 10.49x |
| 2026-04-07 | 9.92x |
| 2026-04-06 | 9.24x |
| 2026-04-02 | 9.92x |
| 2026-04-01 | 10.26x |
| 2026-03-31 | 10.04x |
| 2026-03-30 | 9.24x |
| 2026-03-27 | 9.47x |
| 2026-03-26 | 10.04x |
| 2026-03-25 | 10.04x |
| 2026-03-24 | 9.70x |
| 2026-03-23 | 10.15x |
| 2026-03-20 | 10.37x |
| 2026-03-19 | 10.37x |
| 2026-03-18 | 10.60x |
| 2026-03-17 | 11.16x |
| 2026-03-16 | 11.39x |
| 2026-03-13 | 10.83x |
| 2026-03-12 | 10.15x |
| 2026-03-11 | 10.15x |
| 2026-03-10 | 9.92x |
| 2026-03-09 | 9.58x |
| 2026-03-06 | 8.68x |
| 2026-03-05 | 7.78x |
| 2026-03-04 | 8.45x |
| 2026-03-03 | 8.12x |
| 2026-03-02 | 8.57x |
| 2026-02-27 | 9.13x |
| 2026-02-26 | 13.99x |
| 2026-02-25 | 12.29x |
| 2026-02-24 | 12.76x |
| 2026-02-23 | 12.29x |
| 2026-02-20 | 11.83x |
| 2026-02-19 | 11.83x |
| 2026-02-18 | 11.83x |
| 2026-02-17 | 12.14x |
| 2026-02-13 | 12.29x |
| 2026-02-12 | 14.61x |
| 2026-02-11 | 17.55x |
| 2026-02-10 | 16.93x |
| 2026-02-09 | 16.78x |
| 2026-02-06 | 15.08x |
| 2026-02-05 | 14.92x |
| 2026-02-04 | 14.77x |
| 2026-02-03 | 15.38x |
| 2026-02-02 | 14.92x |
| 2026-01-30 | 15.38x |
| 2026-01-29 | 16.00x |
| 2026-01-28 | 16.00x |
| 2026-01-27 | 16.93x |
| 2026-01-26 | 15.69x |
| 2026-01-23 | 14.61x |
| 2026-01-22 | 15.85x |
| 2026-01-21 | 14.77x |
| 2026-01-20 | 14.30x |
| 2026-01-16 | 14.61x |
| 2026-01-15 | 14.30x |
| 2026-01-14 | 14.92x |
| 2026-01-13 | 14.92x |
| 2026-01-12 | 15.23x |
| 2026-01-09 | 17.09x |
| 2026-01-08 | 16.62x |
| 2026-01-07 | 17.24x |
| 2026-01-06 | 16.31x |
| 2026-01-05 | 16.93x |
| 2026-01-02 | 17.55x |
| 2025-12-31 | 18.48x |
| 2025-12-30 | 18.17x |
| 2025-12-29 | 18.63x |
| 2025-12-26 | 19.25x |
| 2025-12-24 | 19.87x |
| 2025-12-23 | 19.10x |
| 2025-12-22 | 19.25x |
| 2025-12-19 | 19.25x |
| 2025-12-18 | 19.40x |
| 2025-12-17 | 18.48x |
| 2025-12-16 | 18.63x |
| 2025-12-15 | 18.48x |
| 2025-12-12 | 19.25x |
| 2025-12-11 | 19.25x |
| 2025-12-10 | 18.79x |
| 2025-12-09 | 18.01x |
| 2025-12-08 | 18.63x |
| 2025-12-05 | 17.39x |
| 2025-12-04 | 18.17x |
| 2025-12-03 | 17.86x |
| 2025-12-02 | 16.31x |
| 2025-12-01 | 16.93x |
| 2025-11-28 | 18.01x |
| 2025-11-26 | 18.17x |
| 2025-11-25 | 17.86x |
| 2025-11-24 | 18.17x |
| 2025-11-21 | 17.55x |
| 2025-11-20 | 17.39x |
| 2025-11-19 | 18.17x |
| 2025-11-18 | 19.10x |
| 2025-11-17 | 20.80x |
| 2025-11-14 | 19.40x |
| 2025-11-13 | 20.80x |
| 2025-11-12 | 22.19x |
| 2025-11-11 | 21.57x |
| 2025-11-10 | 466.24x |
| 2025-11-07 | 593.05x |
| 2025-11-06 | 582.77x |
| 2025-11-05 | 620.47x |
| 2025-11-04 | 610.19x |
| 2025-11-03 | 620.47x |
| 2025-10-31 | 651.32x |
| 2025-10-30 | 613.62x |
| 2025-10-29 | 613.62x |
| 2025-10-28 | 952.93x |
| 2025-10-27 | 980.35x |
| 2025-10-24 | 932.36x |
| 2025-10-23 | 915.23x |
| 2025-10-22 | 918.65x |
| 2025-10-21 | 963.21x |
| 2025-10-20 | 976.92x |
| 2025-10-17 | 898.09x |
| 2025-10-16 | 894.66x |
| 2025-10-15 | 904.94x |
| 2025-10-14 | 850.11x |
| 2025-10-13 | 846.68x |
| 2025-10-10 | 836.40x |
| 2025-10-09 | 884.38x |
| 2025-10-08 | 870.67x |
| 2025-10-07 | 904.94x |
| 2025-10-06 | 911.80x |
| 2025-10-03 | 863.82x |
| 2025-10-02 | 822.69x |
| 2025-10-01 | 812.41x |
| 2025-09-30 | 829.54x |
| 2025-09-29 | 822.69x |
| 2025-09-26 | 832.97x |
| 2025-09-25 | 822.69x |
| 2025-09-24 | 843.25x |
| 2025-09-23 | 863.82x |
| 2025-09-22 | 850.11x |
| 2025-09-19 | 860.39x |
| 2025-09-18 | 908.37x |
| 2025-09-17 | 853.53x |
| 2025-09-16 | 863.82x |
| 2025-09-15 | 894.66x |
| 2025-09-12 | 904.94x |
| 2025-09-11 | 918.65x |
| 2025-09-10 | 898.09x |
| 2025-09-09 | 922.08x |
| 2025-09-08 | 966.64x |
| 2025-09-05 | 908.37x |
| 2025-09-04 | 928.94x |
| 2025-09-03 | 963.21x |
| 2025-09-02 | 959.78x |
| 2025-08-29 | 970.06x |
| 2025-08-28 | 966.64x |
| 2025-08-27 | 925.51x |
| 2025-08-26 | 952.93x |
| 2025-08-25 | 932.36x |
| 2025-08-22 | 987.20x |
| 2025-08-21 | 987.20x |
| 2025-08-20 | 963.21x |
| 2025-08-19 | 935.79x |
| 2025-08-18 | 959.78x |
| 2025-08-15 | 1007.76x |
| 2025-08-14 | 1021.47x |
| 2025-08-13 | 1024.90x |
| 2025-08-12 | 1031.76x |
| 2025-08-11 | 1042.04x |
| 2025-08-08 | 1066.03x |
